ISSN: 1859 - 2872
Research for clinical and subclinical characteristics in patients of ischemic heart disease with indications for cardiac shock wave therapy
Main Article Content
Keywords
Abstract
Objective: To investigate the clinical and subclinical characteristics in patients of ischemic heart disease with indications for cardiac shock wave therapy at Internal Cardiology Department of the 108 Military Central Hospital. Subject and method: This is a prospective, cross-sectional study on 50 patients with ischemic heart disease with indications for cardiac shock wave therapy managed at Internal Cardiology Department of the 108 Military Central Hospital from January 2017 to January 2020. All patients were performed clinical examination and laboratory tests, learn risk factors onset. Result: The average age of the study group was 71.32 ± 10.5 years, men accounted for 78%. The main risk factors were advanced age (age ≥ 65) 84%, dyslipidemia (96%), hypertension (100%), smoking prevalence (70%), and diabetes (38%). The rate of chest pain grade of CCS 1, respectively, was (2%), CCS 2 (26%), CCS 3 (66%), CCS 4 (6%). The rate of heart failure (64%), in which NYHA II accounted for the highest rate (51.9%). Ejection fraction’s 55.7 ± 16.2% (EF Simpson's 43.3 ± 12%), wall motion septal index (WMSI) 1.49 ± 0.22; global longitudinal strain (GLS) -9.8 ± 2.68. The rate of hypokinesia accounted for the highest rate (98%). Akinesia (8%), dyskinesia (2%), aneurysm (14%). The number of patients without intervention was (30%), with PCI (56%), with CABG (12%). There was 1 patient (2%) with both PCI and CABG. Damage to multiple branches of coronary artery (96%). Severe severity of multiple coronary artery stenosis (58%). The percentage of combined perfusion defect accounted for (100%), severe perfusion defects (52%) and large perfusion defect (58%). Conclusion: Patients with chronic ischemic heart disease with indications for cardiac shock wave therapy are often older, have many risk factors. Coronary artery lesions are many and complicated, and the degree of perfusion defect is severe and extensive.
Article Details
References
2. Crichley J, Capewell S (2004) Smoking cessation for the secondary prevention of coronary heart disease. Cochrane Database Syst. Rev.
3. Bourassa MG (2002) Effect of prior revascularization on outcome following percutaneous coronary intervention; NHLBI Dynamic Registry. Eur Heart J 23(19): 1546-1555.
4. Knuti J, Wijns W (2019) ESC Guidelines for the diagnosis and management of chronic coronary syndromes The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology. Eur Heart J 41(3): 407-477.
5. Prasad M, Wan Ahmad WA, Sukmawan R, Magsombol EB, Cassar A, Vinshtok Y, Ismail MD, Mahmood Zuhdi AS, Locnen SA, Jimenez R, Callleja H, Lerman A (2015) Extracorporeal shockwave myocardial therapy is efficacious in improving symptoms in patients with refractory angina pectoris - a multicenter study. Coronary Artery Disease 26(3): 194-200.
6. Montalescot G, Sechtem U (2013) ESC Guidelines on the management of stable coronary artery disease. Eur. H. Journal 34: 2949-3003.
7. Nielson C, Lange T, Hadjokas N (2006) Blood glucose and coronary artery disease in nondiabetic patients. Diabetes Care 29(5): 998-1001.
8. Shkolnik E, Burneikaitė G, Jakutis G, Scherbak M, Zuozienė G, Petrauskienė B (2018) A randomized, triple-blind trial of cardiac shock-wave therapy on exercise tolerance and symptoms in patients with stable angina pectoris. Coron Artery Dis Coronary Artery Disease 29(7): 579-586.
9. Takakuwa Y, Sarai M, Nagahara Y (2017) Extracorporeal shock wave therapy for coronary artery disease: Relationship of symptom amelioration and ischemia improvement. Asia Ocean J Nucl Med Biol 6(1): 1-9.
10. Vainer J, Habets J, Waltenberger J (2010) Cardiac shockwave therapy in patients with end-stage coronary artery disease and chronic refractory angina pectoris - mild term results. Eur. Heart J 31(1): 198.
Article Sidebar
